Karyopharm Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Karyopharm Therapeutics Inc
TickerKPTI
CIK #0001503802
CUSIP48576U106
SectorLife Sciences - Pharmaceutical Preparations
Address2 Mercer Road, Natick, MA 01760
Source [EDGAR]
CIK Filing 2011 - 2025
[0001503802] 10-K
[0001503802] 10-Q
[0001503802] 3
[0001503802] 4
[0001503802] 5
[0001503802] 8-K
[0001503802] D
[0001503802] SC 13D
[0001503802] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
T Rowe Price Investment Management Inc Karyopharm Therapeutics Inc [2025-08-14] 0.0
JPMorgan Chase & Co Karyopharm Therapeutics Inc [2025-07-16] 0.0
Affinity Asset Advisors LLC Karyopharm Therapeutics Inc [2025-04-10] 0.0
Adage Capital Management LP Karyopharm Therapeutics Inc [2025-02-12] 0.0
Highbridge Capital Management LLC Karyopharm Therapeutics Inc [2024-10-25] 7.2
J Wood Capital Advisors LLC Karyopharm Therapeutics Inc [2024-05-23] 5.5
Vanguard Group Inc Karyopharm Therapeutics Inc [2024-02-13] 7.6
Rubric Capital Management LP Karyopharm Therapeutics Inc [2023-02-10] 7.33
BlackRock Inc Karyopharm Therapeutics Inc [2023-01-20] 10.5
Avidity Partners Management LP Karyopharm Therapeutics Inc [2022-12-08] 0.9
Commodore Capital LP Karyopharm Therapeutics Inc [2022-05-09] 5.1
BlackRock Inc Karyopharm Therapeutics Inc [2022-01-27] 11.8
State Street Corp Karyopharm Therapeutics Inc [2021-02-11] 7.26
BlackRock Inc Karyopharm Therapeutics Inc [2020-12-08] 10.1
Avoro Capital Advisors LLC Karyopharm Therapeutics Inc [2020-02-14] 0.4
State Street Corp Karyopharm Therapeutics Inc [2020-02-13] 5.14
Adage Capital Partners GP LLC Karyopharm Therapeutics Inc [2019-11-18] 6.37
Integrated Core Strategies US LLC Karyopharm Therapeutics Inc [2019-07-23] 4.7
Point72 Asset Management LP Karyopharm Therapeutics Inc [2019-02-27] 5.6
Consonance Capital Management LP Karyopharm Therapeutics Inc [2019-02-14] 7.73
BlackRock Inc Karyopharm Therapeutics Inc [2018-02-01] 5.6
Ridgeback Capital Investments LP Karyopharm Therapeutics Inc [2018-01-26] 5.5
Point72 Asset Management LP Karyopharm Therapeutics Inc [2017-11-06] 7.3
Wellington Management Group LLP Karyopharm Therapeutics Inc [2016-10-11] 11.83
Palo Alto Investors LLC Karyopharm Therapeutics Inc [2016-02-16] 8.71
BlackRock Inc Karyopharm Therapeutics Inc [2015-02-02] 6.0
Franklin Resources Inc Karyopharm Therapeutics Inc [2014-06-10] 11.9
PLIO Ltd Karyopharm Therapeutics Inc [2014-02-18] 10.7
Chione Ltd Karyopharm Therapeutics Inc [2014-02-18] 34.5
FMR LLC Karyopharm Therapeutics Inc [2014-02-14] 0.0
Kauffman Michael Karyopharm Therapeutics Inc [2014-02-14] 5.43
Delphi Ventures VIII LP Karyopharm Therapeutics Inc [2013-11-15] 7.2
Foresite Capital Fund I LP Karyopharm Therapeutics Inc [2013-11-15] 5.6
Form 3/4/5 Filer 2011 - 2025
Karyopharm Therapeutics Inc.
Poulton Stuart
Abate Kristin
Mirza Mansoor Raza
Greene Barry E
Pakianathan Deepika
Schor Chen
Bohlin Garen G
Su Zhen
Oliger Christy J.
Paulson Richard A.
Rangwala Reshma
Cheng Sohanya Roshan
Mano Michael
Macomber Lori
Mason Michael
Honig Peter
Mitchener Stephen
Shacham Sharon
Frenkel Ran
Kauffman Michael
Shah Jatin
Dolsten Mikael
Lewis Tanya
Demaree John
Primiano Christopher Brett
Garland J. Scott
Hadjimichael George
Czernik Marcin
Smolokowski Wiaczeslaw
Hadjimichael Andreas
Chione Ltd
Peters Cameron
Varadan Anand
Thiel Carsten
Falvey Michael
WEG Kenneth E
Todisco Michael
Renz Justin A
Hadjimichael Amalia
Jankilevitsch Gregory
Plio Ltd
Brannelly Paul
Form 13F Holdings
Firm Period DFND Voting Shares
Vanguard Group Inc [2025-06-30] SOLE 0 515,278
Adage Capital Partners GP LLC [2025-06-30] SOLE 421,322 421,322
Eversept Partners LP [2025-06-30] SOLE 257,154 257,154
JPMorgan Chase & Co [2025-06-30] DFND 256,443 256,443
BlackRock, Inc. [2025-06-30] SOLE 236,641 236,641
Citadel Advisors LLC [2025-06-30] DFND 223,005 223,005
Palo Alto Investors LP [2025-06-30] SOLE 187,911 187,911
Bank of America Corp /DE/ [2025-06-30] DFND 0 168,534
UBS Group AG [2025-06-30] DFND 161,900 161,900
Affinity Asset Advisors LLC [2025-06-30] SOLE 157,500 157,500
Catalio Capital Management LP [2025-06-30] SOLE 146,013 146,013
Avidity Partners Management LP [2025-06-30] SOLE 134,566 134,566
Marshall Wace LLP [2025-06-30] OTR 0 128,451
Goldman Sachs Group Inc [2025-06-30] DFND 109,404 109,404
C WorldWide Group Holding A/S [2025-06-30] DFND 100,000 100,000
Group One Trading LLC [2025-06-30] SOLE 97,900 97,900
Geode Capital Management LLC [2025-06-30] DFND 91,841 91,841
Silverback Asset Management LLC [2025-06-30] SOLE 70,000 70,000
Renaissance Technologies LLC [2025-06-30] SOLE 65,814 65,814
Bridgeway Capital Management LLC [2025-06-30] SOLE 37,836 37,836
State Street Corp [2025-06-30] DFND 33,295 33,295
Millennium Management LLC [2025-06-30] SOLE 31,847 31,847
BNP Paribas Financial Markets [2025-06-30] DFND 0 29,637
Birchview Capital LP [2025-06-30] SOLE 27,985 27,985
Ikarian Capital LLC [2025-06-30] SOLE 27,257 27,257
Morgan Stanley [2025-06-30] DFND 22,101 25,091
Northern Trust Corp [2025-06-30] DFND 18,889 18,910
Susquehanna International Group LLP [2025-06-30] OTR 0 16,600
GSA Capital Partners LLP [2025-06-30] SOLE 13,894 13,894
XTX Topco Ltd [2025-06-30] DFND 13,056 13,056
Prev | Page 10 | Next
Terms | Privacy | Guide
tony@aum13f.com